The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Vivax Malaria: Neglected and Not Benign
Open accessAbstract
Plasmodium vivax threatens almost 40% of the world’s population, resulting in 132–391 million clinical infections each year. Most of these cases originate from Southeast Asia and the Western Pacific, although a significant number also occurs in Africa and South America. Although often regarded as causing a benign and self-limiting infection, there is increasing evidence that the overall burden, economic impact, and severity of disease from P. vivax have been underestimated. Malaria control strategies have had limited success and are confounded by the lack of access to reliable diagnosis, emergence of multidrug resistant isolates, the parasite’s ability to transmit early in the course of disease and relapse from dormant liver stages at varying time intervals after the initial infection. Progress in reducing the burden of disease will require improved access to reliable diagnosis and effective treatment of both blood-stage and latent parasites, and more detailed characterization of the epidemiology, morbidity, and economic impact of vivax malaria. Without these, vivax malaria will continue to be neglected by ministries of health, policy makers, researchers, and funding bodies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The economic burden of malaria
Gallup, J., & Sachs, J. (2001) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2001.64.85 · Cited by 1,480
The Resistance Factor to Plasmodium vivax in Blacks: The Duffy-Blood-Group Genotype,FyFy
Miller, L. H., Mason, S. J., Clyde, D. F., & McGinniss, M. H. (1976) · New England Journal of Medicine · doi:10.1056/nejm197608052950602 · Cited by 1,260
The global distribution and population at risk of malaria: past, present, and future
Hay, S. I., Guerra, C. A., Tatem, A. J., Noor, A. M., & Snow, R. W. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01043-6 · Cited by 1,001
Self-citationThe neglected burden of Plasmodium vivax malaria
Mendis, K., Sina, B., Marchesini, P., & Carter, R. (2001) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2001.64.97 · Cited by 970
CONQUERING THE INTOLERABLE BURDEN OF MALARIA: WHAT’S NEW, WHAT’S NEEDED: A SUMMARY
BREMAN, J. G., ALILIO, M. S., & MILLS, A. (2004) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2004.71.2_suppl.0700001 · Cited by 677
PLASMODIUM VIVAX RESISTANCE TO CHLOROQUINE?
Rieckmann, K. H., Davis, D. R., & Hutton, D. C. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91792-3 · Cited by 501
Nosten, F., van Vugt, M., Price, R., Luxemburger, C., Thway, K., Brockman, A., McGready, R., ter Kuile, F., Looareesuwan, S., & White, N. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02505-8 · Cited by 500
Self-citationPrimaquine Therapy for Malaria
Baird, J. K., & Hoffman, S. L. (2004) · Clinical Infectious Diseases · doi:10.1086/424663 · Cited by 435
Factors contributing to anemia after uncomplicated falciparum malaria.
Price, R. N., Simpson, J. A., Nosten, F., Luxemburger, C., Hkirjaroen, L., ter Kuile, F., Chongsuphajaisiddhi, T., & White, N. J. (2001) · The American journal of tropical medicine and hygiene · doi:10.4269/ajtmh.2001.65.614 · Cited by 404
Self-citationKochar, D. K., Saxena, V., Singh, N., Kochar, S. K., Kumar, S. V., & Das, A. (2005) · Emerging Infectious Diseases · doi:10.3201/eid1101.040519 · Cited by 382
Cited by
A new world malaria map: Plasmodium falciparum endemicity in 2010
Gething, P. W., Patil, A. P., Smith, D. L., Guerra, C. A., Elyazar, I. R., Johnston, G. L., Tatem, A. J., & Hay, S. I. (2011) · Malaria Journal · doi:10.1186/1475-2875-10-378 · Cited by 1,146
Self-citationComparative genomics of the neglected human malaria parasite Plasmodium vivax
Carlton, J. M., Adams, J. H., Silva, J. C., Bidwell, S. L., Lorenzi, H., Caler, E., Crabtree, J., Angiuoli, S. V., Merino, E. F., Amedeo, P., et al. (2008) · Nature · doi:10.1038/nature07327 · Cited by 835
Determinants of relapse periodicity in Plasmodium vivax malaria
White, N. J. (2011) · Malaria Journal · doi:10.1186/1475-2875-10-297 · Cited by 679
Self-citationThe changing epidemiology of malaria elimination: New strategies for new challenges
Cotter, C., Sturrock, H. J., Hsiang, M. S., Liu, J., Phillips, A. A., Hwang, J., Gueye, C. S., Fullman, N., Gosling, R. D., & Feachem, R. G. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60310-4 · Cited by 671
Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite
Mueller, I., Galinski, M. R., Baird, J. K., Carlton, J. M., Kochar, D. K., Alonso, P. L., & del Portillo, H. A. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70177-x · Cited by 661
Tjitra, E., Anstey, N. M., Sugiarto, P., Warikar, N., Kenangalem, E., Karyana, M., Lampah, D. A., & Price, R. N. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050128 · Cited by 611
Self-citationArtemisinin-based combination therapies: a vital tool in efforts to eliminate malaria
Eastman, R. T., & Fidock, D. A. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2239 · Cited by 568
(2014) · Tropical Medicine & International Health · doi:10.1111/tmi.12313_2 · Cited by 543
A Long Neglected World Malaria Map: Plasmodium vivax Endemicity in 2010
Gething, P. W., Elyazar, I. R. F., Moyes, C. L., Smith, D. L., Battle, K. E., Guerra, C. A., Patil, A. P., Tatem, A. J., Howes, R. E., Myers, M. F., et al. (2012) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0001814 · Cited by 538
Self-citationThe International Limits and Population at Risk of Plasmodium vivax Transmission in 2009
Guerra, C. A., Howes, R. E., Patil, A. P., Gething, P. W., Van Boeckel, T. P., Temperley, W. H., Kabaria, C. W., Tatem, A. J., Manh, B. H., Elyazar, I. R. F., et al. (2010) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0000774 · Cited by 460
Self-citationHaldar, K., Bhattacharjee, S., & Safeukui, I. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.161 · Cited by 431
Shrinking the malaria map: progress and prospects
Feachem, R. G., Phillips, A. A., Hwang, J., Cotter, C., Wielgosz, B., Greenwood, B. M., Sabot, O., Rodriguez, M. H., Abeyasinghe, R. R., Ghebreyesus, T. A., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61270-6 · Cited by 429
The pathophysiology of vivax malaria
Anstey, N. M., Russell, B., Yeo, T. W., & Price, R. N. (2009) · Trends in Parasitology · doi:10.1016/j.pt.2009.02.003 · Cited by 428
Self-citationGlobal Epidemiology of Plasmodium vivax
Howes, R. E., Battle, K. E., Mendis, K. N., Smith, D. L., Cibulskis, R. E., Baird, J. K., & Hay, S. I. (2016) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.16-0141 · Cited by 418
Battle, K. E., Lucas, T. C. D., Nguyen, M., Howes, R. E., Nandi, A. K., Twohig, K. A., Pfeffer, D. A., Cameron, E., Rao, P. C., Casey, D., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31096-7 · Cited by 409
“10,12,15 The aim of this analysis was to quantify and map clinical P vivax malaria cases and the prevalence of patent blood-stage infections in all P vivax endemic areas from 2000 to 2017.”
The global distribution of the Duffy blood group
Howes, R. E., Patil, A. P., Piel, F. B., Nyangiri, O. A., Kabaria, C. W., Gething, P. W., Zimmerman, P. A., Barnadas, C., Beall, C. M., Gebremedhin, A., et al. (2011) · Nature Communications · doi:10.1038/ncomms1265 · Cited by 395
Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis
Price, R. N., von Seidlein, L., Valecha, N., Nosten, F., Baird, J. K., & White, N. J. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70855-2 · Cited by 388
Self-citationEstimating the Global Clinical Burden of Plasmodium falciparum Malaria in 2007
Hay, S. I., Okiro, E. A., Gething, P. W., Patil, A. P., Tatem, A. J., Guerra, C. A., & Snow, R. W. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000290 · Cited by 374
“vivax malaria [109–112], but new, innovative approaches based on an understanding of the clinical epidemiology and better cartography are required to improve upon current efforts to define the burden due to P.”
BackgroundSelf-citationMerozoite surface proteins in red blood cell invasion, immunity and vaccines against malaria
Beeson, J. G., Drew, D. R., Boyle, M. J., Feng, G., Fowkes, F. J. I., & Richards, J. S. (2016) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuw001 · Cited by 362
New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance
Price, R. N., Douglas, N. M., & Anstey, N. M. (2009) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32832f14c1 · Cited by 343
Self-citationMoon, J. J., Suh, H., Li, A. V., Ockenhouse, C. F., Yadava, A., & Irvine, D. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1112648109 · Cited by 312
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
Bartoloni, A., & Zammarchi, L. (2012) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2012.026 · Cited by 304
New medicines to improve control and contribute to the eradication of malaria
Wells, T. N. C., Alonso, P. L., & Gutteridge, W. E. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2972 · Cited by 298
Drug‐resistant malaria: Molecular mechanisms and implications for public health
Petersen, I., Eastman, R., & Lanzer, M. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.04.042 · Cited by 289
A Research Agenda for Malaria Eradication: Drugs
The malERA Consultative Group on Drugs (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1000402 · Cited by 288
Geographical variation in Plasmodium vivax relapse
Battle, K. E., Karhunen, M. S., Bhatt, S., Gething, P. W., Howes, R. E., Golding, N., Van Boeckel, T. P., Messina, J. P., Shanks, G. D., Smith, D. L., et al. (2014) · Malaria Journal · doi:10.1186/1475-2875-13-144 · Cited by 282
Severe Plasmodium vivax malaria exhibits marked inflammatory imbalance
Andrade, B. B., Reis-Filho, A., Souza-Neto, S. M., Clarêncio, J., Camargo, L. M., Barral, A., & Barral-Netto, M. (2010) · Malaria Journal · doi:10.1186/1475-2875-9-13 · Cited by 273
Advances and challenges in malaria vaccine development
Crompton, P. D., Pierce, S. K., & Miller, L. H. (2010) · Journal of Clinical Investigation · doi:10.1172/jci44423 · Cited by 269
A Research Agenda for Malaria Eradication: Vaccines
The malERA Consultative Group on Vaccines (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1000398 · Cited by 264
Resistance to Therapies for Infection by Plasmodium vivax
Baird, J. K. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00008-09 · Cited by 262
Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination
Wells, T. N. C., Burrows, J. N., & Baird, J. K. (2010) · Trends in Parasitology · doi:10.1016/j.pt.2009.12.005 · Cited by 262
Lacerda, M. V., Mourão, M. P., Alexandre, M. A., Siqueira, A. M., Magalhães, B. M., Martinez-Espinosa, F. E., Santana Filho, F. S., Brasil, P., Ventura, A. M., Tada, M. S., et al. (2012) · Malaria Journal · doi:10.1186/1475-2875-11-12 · Cited by 158
Poespoprodjo, J. R., Fobia, W., Kenangalem, E., Lampah, D. A., Warikar, N., Seal, A., McGready, R., Sugiarto, P., Tjitra, E., Anstey, N. M., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/586743 · Cited by 148
Self-citationDouglas, N. M., Nosten, F., Ashley, E. A., Phaiphun, L., van Vugt, M., Singhasivanon, P., White, N. J., & Price, R. N. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq249 · Cited by 145
Self-citationEpidemiology, drug resistance, and pathophysiology of Plasmodium vivax malaria
Gowda, D., Dayananda, K., & Achur, R. (2018) · Journal of Vector Borne Diseases · doi:10.4103/0972-9062.234620 · Cited by 111
Snow, R. W., Guerra, C. A., Mutheu, J. J., & Hay, S. I. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050142 · Cited by 101
Self-citationPlasmodium vivax Adherence to Placental Glycosaminoglycans
Chotivanich, K., Udomsangpetch, R., Suwanarusk, R., Pukrittayakamee, S., Wilairatana, P., Beeson, J. G., Day, N. P. J., & White, N. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034509 · Cited by 88
“Recent case series suggest this relatively benign reputation may need some revision [6].”
BackgroundSelf-citationUltrasound Evidence of Early Fetal Growth Restriction after Maternal Malaria Infection
Rijken, M. J., Papageorghiou, A. T., Thiptharakun, S., Kiricharoen, S., Dwell, S. L. M., Wiladphaingern, J., Pimanpanarak, M., Kennedy, S. H., Nosten, F., & McGready, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031411 · Cited by 80
Burden and impact of Plasmodium vivax in pregnancy: A multi-centre prospective observational study
Bardají, A., Martínez-Espinosa, F. E., Arévalo-Herrera, M., Padilla, N., Kochar, S., Ome-Kaius, M., Bôtto-Menezes, C., Castellanos, M. E., Kochar, D. K., Kochar, S. K., et al. (2017) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0005606 · Cited by 72
Treating Severe Malaria in Pregnancy: A Review of the Evidence
Kovacs, S. D., Rijken, M. J., & Stergachis, A. (2015) · Drug Safety · doi:10.1007/s40264-014-0261-9 · Cited by 66
Effects of Vivax Malaria Acquired Before 20 Weeks of Pregnancy on Subsequent Changes in Fetal Growth
Machado Filho, A. C., da Costa, E. P., da Costa, E. P., Reis, I. S., Fernandes, E. A. C., Paim, B. V., & Martinez-Espinosa, F. E. (2014) · The American Society of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.13-0285 · Cited by 26
Requena, P., Rui, E., Padilla, N., Martínez-Espinosa, F. E., Castellanos, M. E., Bôtto-Menezes, C., Malheiro, A., Arévalo-Herrera, M., Kochar, S., Kochar, S. K., et al. (2016) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0005009 · Cited by 24
Vivax malaria and chloroquine resistance: a neglected disease as an emerging threat
Waheed, A. A., Ghanchi, N. K., Rehman, K. A., Raza, A., Mahmood, S. F., & Beg, M. A. (2015) · Malaria Journal · doi:10.1186/s12936-015-0660-0 · Cited by 23
Bôtto-Menezes, C., Silva dos Santos, M. C., Lopes Simplício, J., Menezes de Medeiros, J., Barroso Gomes, K. C., de Carvalho Costa, I. C., Batista-Silva, E., Teixeira do Nascimento, C., da Silva Chagas, E. C., Jardim Sardinha, J. F., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0144399 · Cited by 20
“vivax infection can be associated with low birth and anaemia, as it has been described in Thailand, India and Papua (Indonesia) [7–12].”
Background
Metadata
- Authors
- Price, R. N., Tjitra, E., Guerra, C. A., Yeung, S., White, N. J., & Anstey, N. M.
- Venue
- The American Journal of Tropical Medicine and Hygiene
- Published
- 2007-12
- Volume
- 77
- Issue
- 6_Suppl
- Pages
- 79-87
- ISSN
- 0002-9637 (ISSN-L)
- OpenAlex
- W2143838330
- Cited by
- 838
- References
- 75
- FWCI
- 41.30
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.